Agenus (Formerly known as Antigenics Inc. - Lexington, MA) Announces $6.5 Million Registered Direct at the Market Offering
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) today announced that it has received commitments from institutional investors to purchase an aggregate of approximately $6.5 million of its common stock at the market.
Help employers find you! Check out all the jobs and post your resume.